{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:16:22Z","timestamp":1783534582618,"version":"3.55.0"},"reference-count":65,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["22K08379"],"award-info":[{"award-number":["22K08379"]}]},{"name":"JSPS KAKENHI","award":["21K08313"],"award-info":[{"award-number":["21K08313"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>(1) Background: The IL-36 cytokines have been identified as key contributors to pustular psoriasis, and their inhibitor is already in clinical use. However, few studies have explored them in atopic dermatitis. (2) Methods: The role of IL-36\u03b1 was investigated in various atopic dermatitis models using wild-type, keratin 14-specific IL-33 transgenic, IL-18 transgenic, caspase-1 transgenic, and caspase-1 transgenic mice with IL-17AF deletion, reflecting diverse aspects of human skin inflammation. IL-36\u03b1 was administered subcutaneously in five doses on alternate days across the five strains to examine cellular infiltration patterns and cytokine expression levels. (3) Results: The skin phenotype was exacerbated, accompanied by worsening edema and skin thickness in all mouse groups upon IL-36\u03b1 administration. An increase in infiltrating cells was observed among innate immune cells, while lymphocyte counts, including T cells and innate lymphoid cells, did not rise. Additionally, anti-inflammatory cytokines were induced simultaneously with inflammatory cytokines and downstream cytokines of IL-36\u03b1 as well. Infiltrating lymphocytes in the skin displayed a distinct Type 2 cytokine-dominant profile for innate lymphoid cells and a Type 3 cytokine-dominant profile for T helper cells and \u03b3\u03b4 T cells, contrasting with the Type 1-dominant cell profile in draining lymph nodes. Type 1, Type 2, and Type 3 cytokine dominance patterns were not affected by the administration of IL-36\u03b1. (4) Conclusions: IL-36\u03b1 triggers inflammatory responses in atopic dermatitis by activating innate immunity. The infiltrating lymphocytes in the skin have different cytokine production profiles between innate lymphoid cells and T cells, as well as different patterns of cytokine production in their draining lymph nodes.<\/jats:p>","DOI":"10.3390\/biom15060817","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T03:58:52Z","timestamp":1749095932000},"page":"817","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhanced Innate Immunity Mediated by IL-36\u03b1 in Atopic Dermatitis and Differences in Cytokine Profiles of Lymphocytes in the Skin and Draining Lymph Nodes"],"prefix":"10.3390","volume":"15","author":[{"given":"Ayaka","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"},{"name":"Inflammatory Skin Disease Research Center, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"},{"name":"Inflammatory Skin Disease Research Center, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Ichishi","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-5717","authenticated-orcid":false,"given":"Yasutomo","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"},{"name":"Imai Adult and Pediatric Dermatology Clinic, 5-1-1 Ebie, Fukushima, Osaka 553-0001, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-0830","authenticated-orcid":false,"given":"Yoshiaki","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"},{"name":"Inflammatory Skin Disease Research Center, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9934-5775","authenticated-orcid":false,"given":"Yoichiro","family":"Iwakura","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, Graduate School of Agricultural and Life Science, The University of Tokyo, Tokyo 113-8657, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9423-0901","authenticated-orcid":false,"given":"Masatoshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyofumi","family":"Yamanishi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3055-5202","authenticated-orcid":false,"given":"Keiichi","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"},{"name":"Inflammatory Skin Disease Research Center, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12685","article-title":"Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies","volume":"70","author":"Silverberg","year":"2015","journal-title":"Allergy"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the U.K","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jid.2018.04.016","article-title":"The Stenosis of Cerebral Arteries and Impaired Brain Glucose Uptake by Long-Lasting Inflammatory Cytokine Release from Dermatitis Is Rescued by Anti-IL-1 Therapy","volume":"138","author":"Kato","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Nakanishi, T., Iida, S., Maruyama, J., Urushima, H., Ichishi, M., Matsushima, Y., Mizutani, K., Nakayama, Y., Sugioka, K., and Nishimura, M. (2023). Arteriosclerosis Derived from Cutaneous Inflammation Is Ameliorated by the Deletion of IL-17A and IL-17F. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065434"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yamanaka, K., Nakanishi, T., Saito, H., Maruyama, J., Isoda, K., Yokochi, A., Imanaka-Yoshida, K., Tsuda, K., Kakeda, M., and Okamoto, R. (2014). Persistent release of IL-1s from skin is associated with systemic cardio-vascular disease, emaciation and systemic amyloidosis: The potential of anti-IL-1 therapy for systemic inflammatory diseases. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104479"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nakanishi, T., Iida, S., Ichishi, M., Kondo, M., Nishimura, M., Ichikawa, A., Matsushima, Y., Iwakura, Y., Watanabe, M., and Yamanaka, K. (2024). Amelioration of Systemic Amyloidosis by Blocking IL-17A and Not by IL-17F, and Arteriosclerosis by Blocking Both IL-17A and IL-17F in an Inflammatory Skin Mouse Model. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111617"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Iida, S., Nakanishi, T., Momose, F., Ichishi, M., Mizutani, K., Matsushima, Y., Umaoka, A., Kondo, M., Habe, K., and Hirokawa, Y. (2022). IL-17A Is the Critical Cytokine for Liver and Spleen Amyloidosis in Inflammatory Skin Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105726"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Nakanishi, T., Mizutani, K., Iida, S., Matsushima, Y., Umaoka, A., Kondo, M., Habe, K., and Yamanaka, K. (2021). Janus Kinase Inhibitors Ameliorated Gastrointestinal Amyloidosis and Hypoalbuminemia in Persistent Dermatitis Mouse Model. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010028"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jdermsci.2017.05.013","article-title":"Skin inflammation leads immunoglobulin G aggregation and deposition in multiple organs","volume":"88","author":"Yamanaka","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Umaoka, A., Takeuchi, H., Mizutani, K., Seo, N., Matsushima, Y., Habe, K., Hagimori, K., Yamaguchi, Y., Ikeda, T., and Yamanaka, K. (2020). Skin Inflammation and Testicular Function: Dermatitis Causes Male Infertility via Skin-Derived Cytokines. Biomedicines, 8.","DOI":"10.3390\/biomedicines8090293"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mizutani, K., Isono, K., Matsushima, Y., Okada, K., Umaoka, A., Iida, S., Habe, K., Hagimori, K., Yamazaki, H., and Yamanaka, K. (2020). Inflammatory Skin-Derived Cytokines Accelerate Osteoporosis in Mice with Persistent Skin Inflammation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103620"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nishimura, M., Nakanishi, T., Ichishi, M., Matsushima, Y., Watanabe, M., and Yamanaka, K. (2023). Increased Mortality Risk at Septic Condition in Inflammatory Skin Disorders and the Effect of High-Fat Diet Consumption. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010478"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mizutani, K., Shirakami, E., Ichishi, M., Matsushima, Y., Umaoka, A., Okada, K., Yamaguchi, Y., Watanabe, M., Morita, E., and Yamanaka, K. (2020). Systemic Dermatitis Model Mice Exhibit Atrophy of Visceral Adipose Tissue and Increase Stromal Cells via Skin-Derived Inflammatory Cytokines. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093367"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13677","DOI":"10.1074\/jbc.M400117200","article-title":"Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs","volume":"279","author":"Towne","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1042\/BST20230548","article-title":"Molecular aspects of Interleukin-36 cytokine activation and regulation","volume":"52","author":"Keller","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2111563","article-title":"Trial of Spesolimab for Generalized Pustular Psoriasis","volume":"385","author":"Bachelez","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdcr.2023.01.022","article-title":"Spesolimab use in treatment of pyoderma gangrenosum","volume":"34","author":"Guenin","year":"2023","journal-title":"JAAD Case Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdcr.2024.08.035","article-title":"Improvement of acute phase symptoms of pemphigus foliaceus with Spesolimab","volume":"55","author":"Iida","year":"2024","journal-title":"JAAD Case Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.it.2024.12.001","article-title":"Generalized pustular psoriasis: Immunological mechanisms, genetics, and emerging therapeutics","volume":"46","author":"Lee","year":"2025","journal-title":"Trends Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Chen, B.L., Liu, Q.W., Dong, X.W., and Bai, Y.P. (2024). Biologics for generalized pustular psoriasis: A systematic review and single-arm meta-analysis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1462158"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e201900586","DOI":"10.26508\/lsa.201900586","article-title":"Keratinocyte interleukin-36 receptor expression orchestrates psoriasiform inflammation in mice","volume":"3","author":"Leon","year":"2020","journal-title":"Life Sci. Alliance"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/jdv.19935","article-title":"The role of interleukin-36 in health and disease states","volume":"38","author":"Sugiura","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bettiol, A., Fagni, F., Mattioli, I., Bagni, G., Vitiello, G., Grassi, A., Della Bella, C., Benagiano, M., Troilo, A., and Holownia, K.S. (2023). Serum Interleukin-36 alpha as a Candidate Biomarker to Distinguish Behcet\u2019s Syndrome and Psoriatic Arthritis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108817"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4049\/jimmunol.165.2.997","article-title":"Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18","volume":"165","author":"Yamanaka","year":"2000","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Egawa, G., and Weninger, W. (2015). Pathogenesis of atopic dermatitis: A short review. Cogent Biol., 1.","DOI":"10.1080\/23312025.2015.1103459"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0091-6749(96)70246-4","article-title":"In vivo expression of IL-12 and IL-13 in atopic dermatitis","volume":"98","author":"Hamid","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.immuni.2011.07.013","article-title":"Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis","volume":"35","author":"Hershko","year":"2011","journal-title":"Immunity"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13921","DOI":"10.1073\/pnas.1307321110","article-title":"Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice","volume":"110","author":"Imai","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Imai, Y., Hosotani, Y., Ishikawa, H., Yasuda, K., Nagai, M., Jitsukawa, O., Gomi, F., Nakanishi, K., Yoshimoto, T., and Nakamura, T. (2017). Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-10227-y"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1073\/pnas.152337799","article-title":"IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE\/stat6 under specific pathogen-free conditions","volume":"99","author":"Konishi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/77811","article-title":"IL-18 induction of IgE: Dependence on CD4+ T cells, IL-4 and STAT6","volume":"1","author":"Yoshimoto","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin","volume":"192","author":"Foster","year":"2014","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imm.13310","article-title":"IL-36 cytokines and gut immunity","volume":"163","author":"Ngo","year":"2021","journal-title":"Immunology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/5584_2020_488","article-title":"Interleukin-36: Structure, Signaling and Function","volume":"21","author":"Zhou","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00535-022-01936-x","article-title":"Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease","volume":"58","author":"Andoh","year":"2023","journal-title":"J. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Aoyagi, T., Newstead, M.W., Zeng, X., Nanjo, Y., Peters-Golden, M., Kaku, M., and Standiford, T.J. (2017). Interleukin-36\u03b3 and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006737"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.4049\/jimmunol.0803301","article-title":"Externalization of the leaderless cytokine IL-1F6 occurs in response to lipopolysaccharide\/ATP activation of transduced bone marrow macrophages","volume":"183","author":"Martin","year":"2009","journal-title":"J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jid.2022.10.017","article-title":"Cathelicidin Antimicrobial Peptide LL37 Induces Toll-Like Receptor 8 and Amplifies IL-36\u03b3 and IL-17C in Human Keratinocytes","volume":"143","author":"Miura","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s11596-013-1164-1","article-title":"IL-36 cytokine expression and its relationship with p38 MAPK and NF-\u03baB pathways in psoriasis vulgaris skin lesions","volume":"33","author":"He","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"155897","DOI":"10.1016\/j.cyto.2022.155897","article-title":"Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions","volume":"156","author":"Sachen","year":"2022","journal-title":"Cytokine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood-2012-06-439026","article-title":"IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells","volume":"120","author":"Vigne","year":"2012","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chom.2017.10.006","article-title":"Staphylococcus aureus Epicutaneous Exposure Drives Skin Inflammation via IL-36-Mediated T Cell Responses","volume":"22","author":"Liu","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.chom.2017.10.008","article-title":"Staphylococcus aureus Virulent PSM\u03b1 Peptides Induce Keratinocyte Alarmin Release to Orchestrate IL-17-Dependent Skin Inflammation","volume":"22","author":"Nakagawa","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2011.09.010","article-title":"Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E","volume":"35","author":"Chang","year":"2011","journal-title":"Immunity"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Iznardo, H., and Puig, L. (2021). Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094344"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/1744666X.2021.1886081","article-title":"The interleukin-1 family cytokines in psoriasis: Pathogenetic role and therapeutic perspectives","volume":"17","author":"Iznardo","year":"2021","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1007\/s00018-021-03909-4","article-title":"IL-36 cytokines in inflammatory and malignant diseases: Not the new kid on the block anymore","volume":"78","author":"Byrne","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/1744666X.2019.1648209","article-title":"An update on generalized pustular psoriasis","volume":"15","author":"Gooderham","year":"2019","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: Back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e20190418","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wittmann, M., Doble, R., Bachmann, M., Pfeilschifter, J., Werfel, T., and M\u00fchl, H. (2012). IL-27 Regulates IL-18 binding protein in skin resident cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038751"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 Family Cytokines IL-10 and IL-22: From Basic Science to Clinical Translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar3150","article-title":"Type I IFN and TNFalpha cross-regulation in immune-mediated inflammatory disease: Basic concepts and clinical relevance","volume":"12","author":"Cantaert","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","article-title":"Atopic Dermatitis Is an IL-13-Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis","volume":"139","author":"Tsoi","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zysk, W., Sitko, K., Tukaj, S., Zaryczanska, A., and Trzeciak, M. (2023). Altered Gene Expression of IL-35 and IL-36alpha in the Skin of Patients with Atopic Dermatitis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010404"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Balato, A., Zink, A., Babino, G., Buononato, D., Kiani, C., Eyerich, K., Ziehfreund, S., and Scala, E. (2022). The Impact of Psoriasis and Atopic Dermatitis on Quality of Life: A Literature Research on Biomarkers. Life, 12.","DOI":"10.3390\/life12122026"},{"key":"ref_59","first-page":"4298","article-title":"Eczematous reactions in patients with plaque psoriasis receiving biological therapy: An observational study","volume":"28","author":"Burlando","year":"2024","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e14958","DOI":"10.1111\/exd.14958","article-title":"Development of IL-17A inhibitor-induced atopic dermatitis-like rash in psoriasis patients: Insights into immune shift","volume":"33","author":"Li","year":"2024","journal-title":"Exp. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Yamanaka, K., Kono, Y., Iida, S., Nakanishi, T., Nishimura, M., Matsushima, Y., Kondo, M., Habe, K., and Imai, Y. (2023). The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic Dermatitis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043310"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","article-title":"Alarmins: Chemotactic activators of immune responses","volume":"17","author":"Oppenheim","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Moussion, C., Ortega, N., and Girard, J.P. (2008). The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: A novel \u2018alarmin\u2019?. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003331"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.1008647","article-title":"The endogenous Toll-like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer","volume":"86","author":"Ehrchen","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jid.2023.11.004","article-title":"Emerging Role of the IL-36\/IL-36R Axis in Multiple Inflammatory Skin Diseases","volume":"144","author":"Ahmad","year":"2024","journal-title":"J. Investig. Dermatol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/6\/817\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:46:47Z","timestamp":1760032007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/6\/817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":65,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["biom15060817"],"URL":"https:\/\/doi.org\/10.3390\/biom15060817","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]}}}